Streetbeat News

Equity Actions

CXW

Wedbush has reaffirmed its Outperform rating on CoreCivic (NYSE:CXW) and increased its price target from $17.00 to $18.00. CoreCivic's shares have risen 3.6% in the last 24 hours to $15.54. The new price target suggests a potential upside of 15.83%. CoreCivic, a company that operates private prisons and detention centers, has seen the majority of its revenue come from its Safety segment.

Portfolio Pulse from Benzinga Insights

February 09, 2024 | 5:00 pm

VLCN

Volcon's (NYSE:VLCN) short interest has decreased by 38.83% since the last report, with 796 thousand shares sold short, representing 6.98% of its float. This decrease in short interest could indicate a more bullish sentiment towards VLCN among traders. The current short interest is significantly higher than the peer group average of 2.76%, suggesting that VLCN has more bearish sentiment compared to its peers.

Portfolio Pulse from Benzinga Insights

February 09, 2024 | 4:30 pm

HLXB

Helix Acquisition Corp II has officially opened its IPO shares for trade, marking a significant milestone for the company.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 4:09 pm

CVM

CEL-SCI Corporation (NASDAQ:CVM) shares dropped 13.9% to $2.46 after announcing a stock offering of 3.875 million shares at $2.00 each, aiming to raise $7.75 million for Multikine development, general corporate purposes, and working capital. The offering is managed by ThinkEquity and is expected to close on February 13, 2024. The funds will support the commercial-scale production of Multikine for head & neck cancer.

Portfolio Pulse from Henry Khederian

February 09, 2024 | 4:06 pm

BTAI

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) shares fell after announcing a public offering of $60 million in common stock or pre-funded warrants. The offering includes a 30-day option for underwriters to purchase up to $9 million additional shares. Proceeds will fund clinical trials, commercialization, and general corporate purposes. This follows the completion of patient enrollment in a Phase 2 trial of BXCL701 with KEYTRUDA for metastatic pancreatic cancer. BTAI shares dropped 33% to $2.5115.

Portfolio Pulse from Nabaparna Bhattacharya

February 09, 2024 | 4:05 pm

FLNC

Fluence Energy (NASDAQ:FLNC) has been analyzed by 9 financial analysts, showing a mix of bullish to bearish sentiments. The average 12-month price target is $28.67, reflecting a 6.19% increase from the previous target of $27.00. Analysts have adjusted their ratings and price targets based on market conditions and company performance, with several raising their targets. Despite challenges such as a significant revenue decline of -45.92% as of December 31, 2023, and below-average ROE and ROA, Fluence Energy maintains a strong net margin and a prudent debt management strategy.

Portfolio Pulse from Benzinga Insights

February 09, 2024 | 4:00 pm

BLDR

The analysis of Builders FirstSource (BLDR) against its peers in the Building Products industry reveals its undervaluation based on key financial metrics. BLDR shows a lower P/E, P/B, and P/S ratios compared to the industry average, indicating potential undervaluation. Its ROE, EBITDA, and gross profit are above the industry average, demonstrating profitability and operational efficiency. However, its revenue growth is significantly below the industry average, suggesting challenges in sales volume growth.

Portfolio Pulse from Benzinga Insights

February 09, 2024 | 4:00 pm

CVM

Cel-Sci announced a public offering of 3.875 million shares at $2 per share, totaling $7.75 million, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 3:59 pm

TELO

Telomir Pharma's IPO shares began trading at $7 per share, which was also the price at which the IPO was priced.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 3:48 pm

MGX

Metagenomi's IPO is indicating an opening price of $11.50 per share on 413,670 shares, compared to the IPO price of $15 per share on 6.25 million shares.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 3:38 pm